Romanian Translations
Citations 1-23 of 23 total displayed.
Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma
Dimitrios Pectasides, Urania Dafni, Dimitrios Bafaloukos, Dimosthenis Skarlos, Aristidis Polyzos, Dimosthenis Tsoutsos, Haralambos Kalofonos, George Fountzilas, Petros Panagiotou, George Kokkalis, Othon Papadopoulos, Ourania Castana, Stefanos Papadopoulos, Elias Stavrinidis, Georgia Vourli, John Ioannovich, Helen Gogas
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, Joerg T. Hartmann, Jorge Aparicio, Filippo de Braud, Serban Donea, Heinz Ludwig, Gunter Schuch, Christopher Stroh, Anja H. Loos, Angela Zubel, Piotr Koralewski
Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Eric Winer, Julie Gralow, Lisa Diller, Beth Karlan, Patrick Loehrer, Lori Pierce, George Demetri, Patricia Ganz, Barnett Kramer, Mark Kris, Maurie Markman, Robert Mayer, David Pfister, Derek Raghavan, Scott Ramsey, Gregory Reaman, Howard Sandler, Raymond Sawaya, Lynn Schuchter, John Sweetenham, Linda Vahdat, Richard L. Schilsky
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer
Panos M. Fidias, Shaker R. Dakhil, Alan P. Lyss, David M. Loesch, David M. Waterhouse, Jane L. Bromund, Ruqin Chen, Maria Hristova-Kazmierski, Joseph Treat, Coleman K. Obasaju, Martin Marciniak, John Gill, Joan H. Schiller
Discussing Expensive Anticancer Drugs
Michael Jefford, Linda Mileshkin, Penelope Schofield, Emilia Agalianos, Jacqui Thomson, John Zalcberg
Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope
Robin K. Kelley, Alan P. Venook
Surprised by Hope
Prudence A. Francis
Bevacizumab Beyond Progression: Does This Make Sense?
Lee M. Ellis, Daniel G. Haller
Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
Axel Grothey, Mary M. Sugrue, David M. Purdie, Wei Dong, Daniel Sargent, Eric Hedrick, Mark Kozloff
Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
Christopher M. Booth, David W. Cescon, Lisa Wang, Ian F. Tannock, Monika K. Krzyzanowska
Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
Lawrence Fong, Eric J. Small
Across Generations: Cancer Treatment in Developing Countries
Zeba Aziz
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
Andreas Hermes, Bengt Bergman, Roy Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø, Sverre Sörenson
Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
Lori J. Goldstein, Robert Gray, Sunil Badve, Barrett H. Childs, Carl Yoshizawa, Steve Rowley, Steven Shak, Frederick L. Baehner, Peter M. Ravdin, Nancy E. Davidson, George W. Sledge, Jr, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Joseph A. Sparano
SPIKE$: A Six-Step Protocol for Delivering Bad News About the Cost of Medical Care
Joshua McFarlane, Jerry Riggins, Thomas J. Smith
Stage I Testicular Cancer Management and Necessity for Surgical Expertise
Joel Sheinfeld, Robert J. Motzer
Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
Peter Albers, Roswitha Siener, Susanne Krege, Hans-Uwe Schmelz, Klaus-Peter Dieckmann, Axel Heidenreich, Peter Kwasny, Maik Pechoel, Jan Lehmann, Sabine Kliesch, Kai-Uwe Köhrmann, Rolf Fimmers, Lothar Weiβbach, Volker Loy, Christian Wittekind, Michael Hartmann
Hepatic Arterial Infusion Chemotherapy for Metatstases From Colorectal Cancer: Is It Really the End of an Era?
Michael D'Angelica, Yuman Fong, Ronald P. DeMatteo, William R. Jarnagin
In Reply
Ryan A. Wilcox, Benjamin Djulbegovic, Gordon H. Guyatt, Victor M. Montori
Basal-Like Breast Cancer: A Critical Review
Emad A. Rakha, Jorge S. Reis-Filho, Ian O. Ellis
Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
Paul Wheatley-Price, Keyue Ding, Lesley Seymour, Gary M. Clark, Frances A. Shepherd
Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Robert K. Oldham, Robert O. Dillman
Meta-Analysis of Hepatic Arterial Infusion for Unresectable Liver Metastases From Colorectal Cancer: The End of an Era?
Simone Mocellin, Pierluigi Pilati, Mario Lise, Donato Nitti
